本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ocular Therapeutix

9.50
-0.3700-3.75%
盘后9.39-0.1100-1.16%19:50 EDT
成交量:398.41万
成交额:3,803.87万
市值:20.68亿
市盈率:-6.69
高:9.88
开:9.85
低:9.43
收:9.87
52周最高:16.44
52周最低:5.80
股本:2.18亿
流通股本:1.91亿
量比:0.68
换手率:2.09%
股息:- -
股息率:- -
每股收益(TTM):-1.4203
每股收益(LYR):-1.4203
净资产收益率:-54.85%
总资产收益率:-26.66%
市净率:3.16
市盈率(LYR):-6.69

数据加载中...

2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/05

重要事件披露

Form 8-K - Current report
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

重要事件披露

Form 8-K - Current report
2025/12/18

重要事件披露

Form 8-K - Current report